Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 74,195 | 66,378 | 132,070 | 170,262 | 31,014 |
| Marketable Securities | 304,996 | 310,467 | 252,650 | 199,745 | 162,795 |
| Receivables | N/A | N/A | N/A | 30,030 | N/A |
| Other current assets | 4,883 | 5,940 | 4,696 | 4,916 | 4,394 |
| TOTAL | $384,074 | $382,785 | $389,416 | $404,953 | $198,203 |
| Non-Current Assets | |||||
| PPE Net | 3,432 | 2,874 | 2,802 | 2,543 | 2,507 |
| Investments And Advances | 82,488 | 101,986 | 114,172 | 115,452 | 37,492 |
| Other Non-Current Assets | 4,791 | 4,791 | 4,815 | 4,831 | 4,831 |
| TOTAL | $90,711 | $109,651 | $121,789 | $122,826 | $44,830 |
| Total Assets | $474,785 | $492,436 | $511,205 | $527,779 | $243,033 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 269 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,561 | 1,197 | 1,035 | 1,270 | 246 |
| Accrued Expenses | 19,034 | 14,514 | 12,392 | 9,938 | 11,508 |
| TOTAL | $25,715 | $19,822 | $17,553 | $15,187 | $15,664 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,423 | 3,630 | 3,570 | 3,500 | 3,443 |
| Other Non-Current Liabilities | 1,932 | 2,009 | 2,097 | 2,077 | 2,137 |
| TOTAL | $24,616 | $25,671 | $26,712 | $27,862 | $18,670 |
| Total Liabilities | $50,331 | $45,493 | $44,265 | $43,049 | $34,334 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 86,453 | 86,197 | 85,873 | 85,418 | 77,163 |
| Common Shares | 86 | 86 | 86 | 85 | 76 |
| Retained earnings | -915,234 | -885,919 | -851,484 | -827,497 | -826,305 |
| Other shareholders' equity | -977 | -609 | -404 | -179 | -277 |
| TOTAL | $424,454 | $446,943 | $466,940 | $484,730 | $208,699 |
| Total Liabilities And Equity | $474,785 | $492,436 | $511,205 | $527,779 | $243,033 |